Researchers have tested a liposomal nanoparticle loaded with synthetic miRNA-34a mimics (MRX34) against cancer cells combined with the EGFR-TKI Erlotinib (Bader, 2012; Zhao et al., 2014). This evidence concerns the gene EGFR and cancer.